Autologous hematopoietic stem cell transplant in a patient with leprosy: Is it safe?

Show simple item record

dc.contributor Sistema FMUSP-HC: Faculdade de Medicina da Universidade de São Paulo (FMUSP) e Hospital das Clínicas da FMUSP
dc.contributor.author SALOMAO, Matias Chiarastelli FMUSP-HC
BATISTA, Marjorie Vieira FMUSP-HC
MACEDO, Maria Cristina de FMUSP-HC
SOTTO, Mirian Nacagami FMUSP-HC
DUARTE, Amaro Nunes FMUSP-HC
ROCHA, Vanderson Geraldo FMUSP-HC
HIGASHINO, Hermes Ryoiti FMUSP-HC
COSTA, Silvia Figueiredo FMUSP-HC
dc.date.issued 2018
dc.identifier.citation TRANSPLANT INFECTIOUS DISEASE, v.20, n.2, article ID e12840, 4p, 2018
dc.identifier.issn 1398-2273
dc.identifier.uri http://observatorio.fm.usp.br/handle/OPI/26429
dc.description.abstract A patient with non-Hodgkin lymphoma, preparing for an autologous hematopoietic stem cell transplant (HSCT), developed leprosy. The patient was successfully treated with rifampicin, ofloxacin, and doxycycline, and the HSCT was performed without complications, being the first report, to our knowledge, of leprosy in an autologous HSCT patient.
dc.language.iso eng
dc.publisher WILEY
dc.relation.ispartof Transplant Infectious Disease
dc.rights restrictedAccess
dc.subject hematopoietic stem cell transplant; immunocompromised host; leprosy
dc.subject.other of-the-literature; recipient
dc.title Autologous hematopoietic stem cell transplant in a patient with leprosy: Is it safe?
dc.type article
dc.rights.holder Copyright WILEY
dc.description.group LIM/06
dc.description.group LIM/31
dc.description.group LIM/53
dc.description.group LIM/54
dc.identifier.doi 10.1111/tid.12840
dc.identifier.pmid 29359841
dc.type.category original article
dc.type.version publishedVersion
hcfmusp.author SALOMAO, Matias Chiarastelli:HC:ICHC
hcfmusp.author BATISTA, Marjorie Vieira:HC:ICHC
hcfmusp.author MACEDO, Maria Cristina de:HC:ICHC
hcfmusp.author SOTTO, Mirian Nacagami:FM:MPT
hcfmusp.author DUARTE, Amaro Nunes:HC:ICHC
hcfmusp.author ROCHA, Vanderson Geraldo:FM:MCM
hcfmusp.author HIGASHINO, Hermes Ryoiti:HC:ICHC
hcfmusp.author COSTA, Silvia Figueiredo:FM:MIP
hcfmusp.origem.id WOS:000429423400014
hcfmusp.origem.id 2-s2.0-85041926010
hcfmusp.publisher.city HOBOKEN
hcfmusp.publisher.country USA
hcfmusp.relation.reference · Ardalan M, 2011, EXP CLIN TRANSPLANT, V9, P203
· AssociacAo Brasileira de Transplante de rgAos, 2014, DIM TRANSPL BRAS CAD
· Dutra Flávia Albuquerque de Rezende, 2015, J. Bras. Nefrol., V37, P131, DOI 10.5935/0101-2800.20150019
· Gasink LB, 2006, J HEART LUNG TRANSPL, V25, P854, DOI 10.1016/j.healun.2006.03.016
· Lastoria JC, 2014, AN BRAS DERMATOL, V89, P205, DOI 10.1590/abd1806-4841.20142450
· Machado CM, 2009, REV I MED TROP, V51, P309, DOI [10.1590/S0036-46652009000600003, 10.1590/S0036-46652009000600002]
· Pieroni F, 2007, BONE MARROW TRANSPL, V40, P859, DOI 10.1038/sj.bmt.1705824
· Ridley D S, 1966, Int J Lepr Other Mycobact Dis, V34, P255
· Scharschmidt TC, 2013, JAMA DERMATOL, V149, P74, DOI 10.1001/2013.jamadermatol.503
· Secretaria de Vigilancia em SaudeMinisterio da Saude, 2015, REG AT NUM PERC CAS
· Vieira AP, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2406-9
· World Health Organization, LEPR EL
dc.description.index MEDLINE
dc.identifier.eissn 1399-3062
hcfmusp.citation.scopus 0
hcfmusp.citation.wos 0


Files in this item

This item appears in the following Collection(s)

Show simple item record

Search DSpace



Browse

My Account

Statistics